JP2025517341A - マイクロサテライトdna伸長疾患を治療するための組成物及び方法 - Google Patents

マイクロサテライトdna伸長疾患を治療するための組成物及び方法 Download PDF

Info

Publication number
JP2025517341A
JP2025517341A JP2024568205A JP2024568205A JP2025517341A JP 2025517341 A JP2025517341 A JP 2025517341A JP 2024568205 A JP2024568205 A JP 2024568205A JP 2024568205 A JP2024568205 A JP 2024568205A JP 2025517341 A JP2025517341 A JP 2025517341A
Authority
JP
Japan
Prior art keywords
formula
nucleic acid
sirna molecule
acid sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024568205A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025517341A5 (cg-RX-API-DMAC7.html
Inventor
ガラント-ベーム,コリー
ハスラー,マシュー
カーティス,ダニエル
ミゲル ダ クルス ゴディーニョ,ブルーノ
Original Assignee
アタランタ セラピューティクス,インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アタランタ セラピューティクス,インコーポレーテッド filed Critical アタランタ セラピューティクス,インコーポレーテッド
Publication of JP2025517341A publication Critical patent/JP2025517341A/ja
Publication of JP2025517341A5 publication Critical patent/JP2025517341A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/712—Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/322—2'-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/52—Physical structure branched
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C12N2320/11—Applications; Uses in screening processes for the determination of target sites, i.e. of active nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2024568205A 2022-05-16 2023-05-16 マイクロサテライトdna伸長疾患を治療するための組成物及び方法 Pending JP2025517341A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263342552P 2022-05-16 2022-05-16
US63/342,552 2022-05-16
PCT/US2023/067039 WO2023225495A2 (en) 2022-05-16 2023-05-16 Compositions and methods for treatment of microsatellite dna expansion disorders

Publications (2)

Publication Number Publication Date
JP2025517341A true JP2025517341A (ja) 2025-06-05
JP2025517341A5 JP2025517341A5 (cg-RX-API-DMAC7.html) 2026-05-22

Family

ID=88836271

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024568205A Pending JP2025517341A (ja) 2022-05-16 2023-05-16 マイクロサテライトdna伸長疾患を治療するための組成物及び方法

Country Status (7)

Country Link
US (1) US20250346897A1 (cg-RX-API-DMAC7.html)
EP (1) EP4525887A2 (cg-RX-API-DMAC7.html)
JP (1) JP2025517341A (cg-RX-API-DMAC7.html)
CN (1) CN119866220A (cg-RX-API-DMAC7.html)
AU (1) AU2023272008A1 (cg-RX-API-DMAC7.html)
CA (1) CA3257128A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023225495A2 (cg-RX-API-DMAC7.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021216556A2 (en) * 2020-04-20 2021-10-28 University Of Massachusetts Oligonucleotides for msh3 modulation

Also Published As

Publication number Publication date
WO2023225495A3 (en) 2023-12-28
EP4525887A2 (en) 2025-03-26
CA3257128A1 (en) 2023-11-23
US20250346897A1 (en) 2025-11-13
WO2023225495A2 (en) 2023-11-23
CN119866220A (zh) 2025-04-22
WO2023225495A8 (en) 2024-01-25
AU2023272008A1 (en) 2024-12-12

Similar Documents

Publication Publication Date Title
JP2025531482A (ja) 微小管結合タンパク質タウ核酸を標的化するsiRNA組成物及び方法
JP2025532885A (ja) 神経変性疾患の処置のための組成物及び方法
JP2025531512A (ja) アルファシヌクレイン核酸を標的化するsiRNA組成物及び方法
JP2024542738A (ja) 疼痛の治療のための組成物及び方法
JP2025532886A (ja) 神経疾患の処置のための組成物及び方法
JP2025531483A (ja) 神経炎症疾患の治療のための組成物及び方法
EP4413136A1 (en) Compositions and methods for treatment of prion diseases
JP2025531484A (ja) 神経炎症性疾患の処置のための組成物及び方法
AU2023272008A1 (en) Compositions and methods for treatment of microsatellite dna expansion disorders
JP2025531481A (ja) 脊髄小脳変性症の治療のための組成物及び方法
JP2024542728A (ja) てんかんの治療のための組成物及び方法
JP2026509929A (ja) 改善された遺伝子サイレンシングのための組成物及び方法
JP2025532883A (ja) ハンチントン病の治療のための組成物及び方法

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20251008

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20251008

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260514

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260514